XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Performance Share Units
Restricted Stock Units
Treasury Shares
Treasury Shares
Performance Share Units
Treasury Shares
Restricted Stock Units
Common stock
Common stock
Performance Share Units
Common stock
Restricted Stock Units
Preferred Shares Issued
Additional Paid-In Capital
Additional Paid-In Capital
Performance Share Units
Additional Paid-In Capital
Restricted Stock Units
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Shares, beginning balance (in shares) at Dec. 31, 2021       (15,797)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2021             47,018                
Preferred Shares Issued, beginning balance (in shares) at Dec. 31, 2021                   10          
Beginning balance at Dec. 31, 2021 $ 429,702     $ (227,115)     $ 470     $ 0 $ 108,202     $ 563,713 $ (15,568)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)         9 [1] 27 [1]   33 111            
Vesting of equity instruments other than options   $ (104) $ (314)   $ (104) $ (314)   $ 1 $ 1     $ (1) $ (1)    
Grants of restricted stock awards (in shares)             53                
Retirement of treasury shares (in shares)       (36) [1]     (36)                
Retirement of treasury shares 0     $ 418             (418)        
Purchases of treasury stock (in shares)       (993)                      
Purchases of treasury stock (11,643)     $ (11,643)                      
Share-based compensation 4,727                   4,727        
Net income (loss) (22,257)                         (22,257)  
Other comprehensive income (loss), net of taxes (88,214)                           (88,214)
Declaration of dividends (24,001)                         (24,001)  
Treasury Shares, ending balance (in shares) at Dec. 31, 2022       (16,790)                      
Common Shares Issued, ending balance (in shares) at Dec. 31, 2022             47,179                
Preferred Shares Issued, ending balance (in shares) at Dec. 31, 2022                   10          
Ending balance at Dec. 31, 2022 287,896     $ (238,758)     $ 472     $ 0 112,509     517,455 (103,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)         6 [1] 16 [1]   16 48            
Vesting of equity instruments other than options   $ (64) (160)   $ (64) $ (160)                  
Grants of restricted stock awards (in shares)             36                
Stock option exercises, shares (in shares)       82 [1]     94                
Stock option exercises 1,276     $ (115)             1,391        
Retirement of treasury shares (in shares)       (104) [1]     (104)                
Retirement of treasury shares (1,391)     $ 339             (1,730)        
Purchases of treasury stock (in shares)       (1,513)                      
Purchases of treasury stock (22,021)     $ (22,021)                      
Share-based compensation 5,006                   5,006        
Other [2] (2,090)                   (2,090)        
Net income (loss) 66,823                         66,823  
Other comprehensive income (loss), net of taxes 29,610                           29,610
Declaration of dividends $ (23,588)                         (23,588)  
Treasury Shares, ending balance (in shares) at Dec. 31, 2023 (18,303)     (18,303)                      
Common Shares Issued, ending balance (in shares) at Dec. 31, 2023 47,269           47,269                
Preferred Shares Issued, ending balance (in shares) at Dec. 31, 2023 10                 10          
Ending balance at Dec. 31, 2023 $ 341,297     $ (260,779)     $ 472     $ 0 115,086     560,690 (74,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)           68 [1]     248            
Vesting of equity instruments other than options     $ (1,418)     $ (1,418)     $ 3       $ (3)    
Grants of restricted stock awards (in shares)             28                
Stock option exercises, shares (in shares)       2 [1]     3                
Stock option exercises (1)     $ (55)             54        
Retirement of treasury shares (in shares)       (70) [1]     (70)                
Retirement of treasury shares 0     $ 1,473             (1,473)        
Purchases of treasury stock (in shares)       (1,079)                      
Purchases of treasury stock (21,914)     $ (21,914)                      
Share-based compensation 8,627                   8,627        
Other [2] (510)                   (510)        
Net income (loss) 58,928                         58,928  
Other comprehensive income (loss), net of taxes 11,006                           11,006
Declaration of dividends $ (22,765)                         (22,765)  
Treasury Shares, ending balance (in shares) at Dec. 31, 2024 (19,382)     (19,382)                      
Common Shares Issued, ending balance (in shares) at Dec. 31, 2024 47,478           47,478                
Preferred Shares Issued, ending balance (in shares) at Dec. 31, 2024 10                 10          
Ending balance at Dec. 31, 2024 $ 373,250     $ (282,693)     $ 475     $ 0 $ 121,781     $ 596,853 $ (63,166)
[1] All shares acquired represent shares tendered to cover the strike price for options and tax withholdings on the intrinsic value of stock options exercised, restricted stock vested, performance share units vested, or restricted stock units vested. These shares have been cancelled by the Company.
[2]
As of December 31, 2024 and December 31, 2023, the Other line within Paid-in Capital includes $0.5 million and $2.1 million, respectively, in connection with the cash settlement of certain restricted stock units.